期刊文献+

肥胖儿童非酒精性脂肪肝病与胰岛素抵抗的关系 被引量:9

Nonalcoholic Fatty Liver Disease and Insulin Resistance in Obese Children
下载PDF
导出
摘要 目的探讨肥胖儿童非酒精性脂肪肝(NAFLD)与胰岛素抵抗之间的关系。方法采用对照研究,分别测量肥胖合并NAFLD(脂肪肝组)患儿和单纯肥胖不伴NAFLD(单纯肥胖组)患儿的身高、体质量,并检测两组患儿的血糖、血脂、尿酸水平。行口服葡萄糖耐试验和胰岛素释放试验,计算体质指数(BMI)和胰岛素抵抗指数(HOMA-IR)。结果两组患儿的BMI、三酰甘油(TG)、总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、尿酸、空腹血糖(FPG)、空腹胰岛素(FINS)、口服葡萄糖耐量试验2h血糖(2hPG)和2h胰岛素(2hFINS)及HOMA-IR间差别均有统计学意义(P<0.05)。结论肥胖儿童中合并NAFLD者存在严重的胰岛素抵抗和脂代谢异常,胰岛素抵抗可能是儿童NAFLD的发病机制之一。 Objective To investigate the relationship between nonalcoholic fatty liver disease (NAFLD) and insulin resistance in obese children. Methods The contractive study was taken to measure the height and weight of the body, and the levels of blood sugar, lipid and uric acid of the children patients in the NAFLD group and simple obese group. Oral glucose tolerance test and insulin releasing test were performed. The body mass index (BMI) and homeostasis model assessment - insulin resistance (HOMA -IR) were calculated. Results The BMI, total cholesterol (TC), triglyceride (TG), lower density lipoprotein - cholesterol (LDL - C) and uric acid of children in NAFLD group were obviously higher than those in simple obese group, while the value of 2 - h postprandial blood glucose (2h - PG) in oral glucose tolerance test and HOMA - IR were significantly elevated in the NAFLD compared with those in simple obese group ( P 〈 0. 05 ). Conclusion The obese children complicated by NAFLD have a severe insulin resistance and an metabolite disturbance of serum lipid, and insulin resistance may be one of the significant pathogenesis for NAFLD.
出处 《中国全科医学》 CAS CSCD 2008年第21期1928-1929,共2页 Chinese General Practice
关键词 脂肪肝 非酒精性 肥胖症 儿童 胰岛素抵抗 Fatty liver, non alcoholic Obesity Child Insulin resistance
  • 相关文献

参考文献10

  • 1Brunt EM. Nonalcoholic steatohepatitis: definition and pathology [ J ]. Sem in Liver Dis , 2001, 21 (1): 3-16.
  • 2Harrison SA, Diehl AM. Fat and the liver - a molecular overview [J]. Sere in Gastrointestin Dis, 2002, 13 (1) : 3 -16.
  • 3周淑新,陈叶.非酒精性脂肪肝病[J].中国全科医学,2006,9(19):1616-1618. 被引量:4
  • 4Bloomgarden ZT. Second World Congress on the Insulin Resistance Syndrome: insulin resistance syndrome and nonalcoholic fatty liver disease [J]. Diabetes Care, 2005, 28 (6) : 1518 -1523.
  • 5Luyckx FH, Lefebvre PJ, Scheen AJ. Non - alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss [J]. Diabetes Metab, 2000, 26 (2): 98-106.
  • 6Medina J, Femandez -Salazar LI, Garcia - Buey L, et al. Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis [J].Diabetes Care, 2004, 27 (8): 2057-2066.
  • 7Marchesini G, Brizi M, Bianchi G, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome [J]. Diabetes, 2001, 50 (8) : 1844 -1850.
  • 8Sanyal A J, Campbell- Sargent C, Mirshahi F, et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities [J]. Gastroenterology, 2001, 120 (5): 1183-1192.
  • 9张冬梅,张桂英,王涛,钟惠菊,陈文科.改善胰岛素抵抗药物治疗大鼠非酒精性脂肪肝病的实验研究[J].中华医学杂志,2006,86(18):1279-1283. 被引量:14
  • 10Nobili V, Mareellini M, Devito R. NAFLD in children: a prospective clinical- pathological study and effect of lifestyle advice [ J ]. Hepatology, 2006, 44 (2): 458-465.

二级参考文献13

  • 1沈薇.非酒精性脂肪肝的药物治疗[J].中华肝脏病杂志,2005,13(2):139-139. 被引量:25
  • 2Neuschwander-Tetri B,Caldwell S.Nonalcoholic steatohepatitis:summary of an AASLD single topic conference.Hepatology,2003,37:1202-1219.
  • 3Brunt EM.Nonalcoholic steatohepatitis:definition and pathology.Semin Liver Dis,2001,21:3-16.
  • 4Harrison SA,Diehl AM.Fat and the liver-a molecular overview.Semin Gastrointestin Dis,2002,13:3-16.
  • 5Bloomgarden ZT.Second World Congress on the Insulin Resistance Syndrome:insulin resistance syndrome and nonalcoholic fatty liver disease.Diabetes Care,2005,28:1518-1523.
  • 6Eldershaw TP,Rattigan S,Cawthorne MA,et al.Treatment with the thiazolidinedione (BRL 49653) decreases insulin resistance in obese Zucker hindlimb.Horm Metab Res,1995,27:169-172.
  • 7Zhang XF,Tan BK.Effects of an ethanolic extract of Gynura procumbens on serum glucose,cholesterol and triglyceride levels in normal and streptozotocin-induced diabetic rats.Singapore Med J,2000,41:9-13.
  • 8Kanauchi M.A new index of insulin sensitivity obtained from the oral glucose tolerance test applicable to advanced type 2 diabetes.Diabetes Care,2002,25:1891-1892.
  • 9Xu A,Wang Y,Keshaw H,et al.The fat-derived hormone adiponectin alleviated alcoholic and nonalcoholic fatty liver disease in mice.J Clin Invest,2003,112:91-100.
  • 10Li Z,Yang S,Lin H,et al.Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver diasease.Hepatology,2003,37:343-350.

共引文献16

同被引文献78

  • 1宋群,盖淑香,冯燕,张贵林.脂肪肝的运动疗法[J].中国疗养医学,2004,13(4):215-216. 被引量:5
  • 2吕瑛,徐肇敏,李运红.胰岛素抵抗在大鼠实验性非乙醇性脂肪肝中的作用[J].江苏大学学报(医学版),2005,15(5):373-376. 被引量:3
  • 3高鑫.非酒精性脂肪肝与胰岛素抵抗[J].中国糖尿病杂志,2006,14(5):321-322. 被引量:23
  • 4中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪肝病诊疗指南.中华肝脏病杂志,2006,14(2):161-161.
  • 5Andersen T,Gluud C.Liver morphology in morbid obesity:a literature study[J].Int J Obes,1984,8:97-106.
  • 6Bellentani S,Saccocio G,Masutti F,et al.Prevalence of and risk factors for hepatic steatosis in northern Italy[J].Ann Intern Med,2000,132:112-117.
  • 7Guenther Boden.Fatty acid-induced inflammation and insulin resistance in skeletal muscle and liver[J].Current Science Inc,2006,6:177-181.
  • 8Fan JG,Saibara T,Chitturi S,et al.What are the risk factors andsettings for non-alcoholic fatty liver disease in Asia-Pacific?[J].J Gastroenterol Hepatol,2007,22:794-800.
  • 9Fan JG.Impact of non-alcoholic fatty liver disease on accelerated metabolic complications[J].J Dig Dis,2008,9(2):63-67.
  • 10朱红霞 朱筠 张明琛 等.维吾尔族和汉族2型糖尿病合并非酒精性脂肪肝患者的代谢特征及相关危险因素探讨.中国全科医学,2009,12(7):1164-1164.

引证文献9

二级引证文献110

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部